Market Research Insights

  San Francisco, 17 Aug 2022:  The Report  Life Sciences BPO Market  Size, Share & Trends Analysis Report By Service (Medical Devices Outsourcing, Pharmaceutical Outsourcing), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030 The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.2% over the forecast years, according to a new report by Grand View Research, Inc. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are some of the major factors driving the market. The pharmaceutical and biotech industries invest heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of drug development, such as drug discovery, pre-clinical studies, and clinical trials, require huge financial, techno...

San Francisco, 10 April 2019:  The Report  Life Sciences BPO Market  Analysis by Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales, Marketing Outsourcing), and Segment Forecasts to 2024 The Life Sciences BPO Market is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services. The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources. In order to cater to the growing needs of the i...